If you’ve spent any time in longevity content — the podcasts, the protocols, the VO2 max obsession, the cold plunge discourse — you may have noticed something. The default subject is almost always male. The data is male. The optimization is calibrated for male physiology. The case studies are men who’ve run their biomarkers through every available test and emerged with a 10-step morning protocol.

This isn’t incidental. It reflects a deeper structural problem in how longevity medicine has been built — and it’s starting to change, in significant part because women are demanding better.

A 2024 McKinsey report found that women spend 25% more of their lives in poor health compared to men — not because women are inherently less healthy, but because of diagnostic delays, lack of sex-specific research, and treatments calibrated for a male default. A study published in JAMA Network Open found that women have a 2.6-year higher healthspan-lifespan gap than men — meaning women live longer, but spend more of those extra years in poor health.

That’s the gap longevity medicine needs to close. And here are the questions every woman should be asking to close it for herself.

Why the Longevity Market Has a Women Problem

The longevity industry — worth billions in supplements, diagnostics, wearables, and clinical programs — has largely been built on data from male subjects. This goes back decades. Until 1993, women were routinely excluded from clinical trials. The NIH’s own research acknowledges persistent underrepresentation of women in studies, inadequate sex-disaggregated data, and structural biases in how women’s symptoms are interpreted.

The practical consequence: many of the protocols promoted in the longevity space were developed without accounting for hormonal variation, the menstrual cycle’s effect on metabolism and recovery, the dramatically different cardiovascular risk profile women face post-menopause, or the ways women’s bodies respond differently to fasting, high-intensity exercise, and caloric restriction.

What works for a 45-year-old man may not work — and in some cases may actively harm — a 45-year-old woman. This isn’t a reason to dismiss the longevity conversation. It’s a reason to enter it with better questions.

The Questions That Actually Matter for Women’s Longevity

What Does My Hormonal Baseline Look Like — And Is Anyone Tracking It Over Time?

Hormones are the most undermonitored aspect of women’s long-term health. Estrogen, progesterone, testosterone, cortisol, thyroid hormones, and insulin all interact in ways that significantly affect energy, metabolism, cardiovascular health, bone density, cognitive function, and mood. Most women’s hormonal health is only evaluated when something goes wrong — not proactively, as a baseline for optimization.

The question to ask your doctor: “Can we establish a hormonal baseline now and track changes over time?” This is especially important in the decade before perimenopause, when shifts begin and are frequently dismissed or misattributed to stress or anxiety. Early data creates early options.

What Is My Cardiovascular Risk Profile — Adjusted for My Sex?

Heart disease is the leading cause of death in women, killing more women each year than all cancers combined, according to the CDC. Yet women are less likely to be screened aggressively for cardiovascular risk, less likely to present with “classic” heart attack symptoms (which were largely defined by male patient data), and more likely to have heart disease misdiagnosed or diagnosed later.

Women’s cardiovascular risk surges post-menopause when the protective effect of estrogen declines. This means the window for preventive action — building cardiovascular fitness, managing lipids, monitoring blood pressure — is most impactful in your 30s and 40s, well before menopausal changes begin. Ask for a comprehensive cardiovascular panel, not just total cholesterol: LDL particle size, triglycerides, Lp(a), ApoB, and inflammatory markers like hsCRP are all relevant.

How Does My Exercise Prescription Account for My Hormonal Cycle?

Emerging research suggests that women’s responses to exercise — including recovery time, injury risk, and performance — vary across the menstrual cycle. The follicular phase (roughly days 1–14) is generally associated with higher energy, better recovery, and the capacity for higher-intensity work. The luteal phase (days 14–28) tends to favor lower-intensity, higher-volume training with longer recovery windows.

Most exercise protocols don’t account for this variation. Asking your trainer or sports medicine doctor about cycle-synced training isn’t fringe — it’s evidence-informed personalization. If they dismiss the question, that’s a data point about whether they’re the right provider for you.

Am I Fasting in a Way That Supports My Hormones Rather Than Disrupting Them?

Intermittent fasting has been extensively promoted as a longevity tool — largely based on research conducted on male subjects. The picture for women is more complicated. Some research suggests that extended fasting periods can disrupt cortisol rhythms, affect menstrual regularity, and trigger HPA axis dysregulation in women, particularly those who are already under stress or undereating.

This doesn’t mean fasting is harmful for all women. It means the 16:8 protocol that works brilliantly for a male subject may not be the right starting point for you. Time-restricted eating with a shorter fasting window (12–14 hours, overnight) is generally better tolerated and may provide similar metabolic benefits without the hormonal cost. Ask a provider who understands women’s physiology before committing to aggressive fasting schedules.

What Is My Bone Density Trajectory — Not Just My Current Reading?

Bone density peaks in your late 20s and begins declining through your 30s. The rate of decline accelerates significantly around perimenopause and post-menopause. Osteoporosis affects an estimated 10 million Americans, with 80% of them being women, according to the NIH.

A baseline DEXA scan in your late 30s or early 40s — rather than waiting until the standard screening age of 65 — gives you a trajectory, not just a snapshot. Knowing your bone density trend early means you can intervene with resistance training, calcium and vitamin D optimization, and when appropriate, hormone therapy, well before significant loss occurs.

What Does Cognitive Health Look Like for Women Specifically?

Women represent approximately two-thirds of all Alzheimer’s cases, according to the Alzheimer’s Association — and researchers are increasingly linking this disparity to hormonal transitions, particularly the decline in estrogen during menopause. Cognitive longevity for women may require a different set of interventions than for men.

The preventive levers that have the strongest evidence: cardiovascular fitness (blood flow to the brain), sleep quality (glymphatic clearance of metabolic waste), stress management (cortisol’s effect on the hippocampus), and possibly hormone therapy at the right window — though this area of research is still evolving. Ask your provider about cognitive health as a longevity priority, not just a late-in-life concern.

How to Find Providers Who Take This Seriously

Not every physician or health practitioner is trained in women-specific longevity medicine. The field is growing — look for practitioners board-certified in internal medicine, obstetrics/gynecology, or functional medicine with explicit focus on women’s preventive health. Organizations like the Menopause Society maintain directories of certified menopause practitioners. For broader longevity medicine, look for clinicians affiliated with research institutions that specifically include women in their studies.

The standard of “my doctor didn’t raise it so it probably doesn’t matter” isn’t sufficient in a medical system that has historically underserved women’s health. The women who get the best long-term health outcomes are the ones who bring specific, informed questions to every appointment — and don’t accept dismissal as a diagnosis.

Disclaimer: This article is for informational purposes only and does not constitute professional medical advice. Always consult a qualified healthcare provider before making changes to your health regimen.

FAQ

Q: Why has longevity medicine been focused on men?
A: Until 1993, women were routinely excluded from clinical trials. The data underpinning most health and longevity protocols was built on male subjects, and the field is only now catching up with women-specific research.

Q: What’s the most important longevity test women should ask for?
A: There’s no single most important test — the combination matters. A comprehensive hormonal panel, a full cardiovascular workup (including ApoB and Lp(a)), a DEXA scan for bone density, and metabolic markers like fasting glucose and insulin are a strong starting baseline.

Q: Is intermittent fasting safe for women?
A: It depends on the protocol and your individual physiology. Extended fasting (16+ hours) can disrupt hormones in some women. A 12–14 hour overnight fast is generally better tolerated. Always consult a healthcare provider familiar with women’s physiology before committing to a fasting protocol.

Q: What age should women start taking longevity health seriously?
A: Preventive action is most impactful in your 30s and early 40s — well before the hormonal shifts of perimenopause begin. Establishing baselines early means you have data to act on, rather than scrambling to catch up.

Q: Where can I find a physician who specializes in women’s longevity?
A: The Menopause Society (menopausesociety.org) maintains a directory of certified menopause practitioners. For broader longevity medicine, look for clinicians with training in internal medicine or functional medicine who explicitly focus on women’s preventive health.